InvestorQ : What will be the implications of Gilead approval for Cipla and Jubilant?
Anamika Sodhani made post

What will be the implications of Gilead approval for Cipla and Jubilant?

Answer
user profile image
3 months ago


India gave its approval for Gilead's Remdesivir, an anti viral drug for COVID-19 cure for emergency use. Remdesivir already has emergency approval from the USFDA. Gilead has given approval to Cipla, Jubilant Life, Hetero and Mylan for royalty free manufacture as a special gesture. With the Indian government approval, the Indian pharma companies can also make the drug available in India.